Stocks and InvestingStocks and Investing
Thu, July 6, 2023
Wed, July 5, 2023
Mon, July 3, 2023
Fri, June 30, 2023

Rebecca Liang Downgraded (BGNE) to Hold and Decreased Target to $196 on, Jun 30th, 2023


Published on 2024-10-28 04:36:25 - WOPRAI, Rebecca Liang
  Print publication without navigation


Rebecca Liang of Bernstein, Downgraded "BeiGene, Ltd." (BGNE) to Hold and Decreased Target from $335 to $196 on, Jun 30th, 2023.

Rebecca has made no other calls on BGNE in the last 4 months.



There are 4 other peers that have a rating on BGNE. Out of the 4 peers that are also analyzing BGNE, 1 agrees with Rebecca's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Li of "B of A Securities" Maintained at Hold with Increased Target to $263 on, Wednesday, April 12th, 2023


These are the ratings of the 3 analyists that currently disagree with Rebecca


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $321 on, Tuesday, February 28th, 2023
  • Michael Schmidt of "Guggenheim" Reiterated at Strong Buy and Held Target at $350 on, Tuesday, February 28th, 2023
  • Yaron Weber of "Cowen & Co." Maintained at Buy with Increased Target to $262 on, Tuesday, February 28th, 2023